Abott Laboratories

Company snapshot

Abbott Laboratories is a pharma organization headquartered in Moscow, RU. Primary therapeutic focus areas include Influenza immunisation. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources. Pipeline phase mix: phase 3 (1).

• 1 active pipeline program(s) linked via ClinicalTrials.gov.
• 25 US patent(s) indexed to this assignee profile.
• 1 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Abott Laboratories. Not investment advice.

Recent activity

Latest pipeline, patent, and corporate events for Abott Laboratories.

1. Jun 8, 2026 Clinical update

   INFQ-324-0476 — Phase 3

2. Feb 19, 2026 Patent grant

   BÉTAÏNE ET FOLATE POUR FAVORISER LA MATURATION DU CERVEAU D'UN NOURRISSON

3. Jan 8, 2026 Patent grant

   FORMULATIONS NUTRITIONNELLES PERMETTANT DE MAINTENIR DES MICROBIOTE ET FONCTION INTESTINAUX SAINS

4. Jun 5, 2025 Patent grant

   COMPOSITION À LIBÉRATION MODIFIÉE

5. Feb 6, 2025 Patent grant

   PROCÉDÉS ET COMPOSITIONS POUR LE MAINTIEN DE LA MOBILITÉ ET/OU DE LA MASSE DES MUSCLES SQUELETTIQUES, ET/OU POUR LA RÉCUPÉRATION DE LA FORCE DES MUSCLES SQUELETTIQUES

View all clinical trial activity →

• What is Abott Laboratories?

  Abbott Laboratories is a pharma organization headquartered in Moscow, RU. Primary therapeutic focus areas include Influenza immunisation. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov,

• Is Abott Laboratories publicly traded?

  Abott Laboratories appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does Abott Laboratories develop or market?

  We link 4 drug profile(s) where Abott Laboratories is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/abbott-laboratories#company-drugs.

• What are the latest developments for Abott Laboratories?

  In the last 12 months our linked public records show 1 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does Abott Laboratories focus on?

  Abott Laboratories focuses on Influenza immunisation based on our analysis of their pipeline programs and drug development activities.